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Taxoids are natural compounds isolated from the bark or leaves of yew trees and screened for their antiproliferative properties. Taxol or paclitaxel was initially selected on the basis of its cytotoxic properties upon various cell lines and tumor-bearing mice; its biological action was attributed to the capacity to bind tubulin and to stabilize microtubules, thus modifying the cytoskeleton architecture and blocking the cell cycle in phase G2/M (Wani et al., 1971; Schiff et al., 1979) . However, the limited availability of paclitaxel led to the development of analogs, which retained the biological activity on tubulin assembly but were readily synthesized in large quantities. This led to the discovery of docetaxel (Taxotere) a semisynthetic compound derived from 10-deacetylbaccatin III with an affinity for microtubules 2 times higher than paclitaxel (Ringel and Horwitz, 1991) . Paclitaxel and docetaxel are widely used with success in patients with various tumors, including ovarian or breast carcinomas resistant to conventional chemotherapy (Rowinski et al., 1992) .
The therapeutic efficiency of taxoids is the result of the balance between their biological action on tubulin and rate of degradation. The elimination of paclitaxel and docetaxel from the body occurs mainly through the biliary route. Five metabolites are isolated from the bile of a patient given paclitaxel and three are hydroxylated (Monsarrat et al., 1993) . The complete chemical structure of these metabolites has been established by mass spectrometry and NMR spectrometry (Monsarrat et al., 1993 (Monsarrat et al., , 1998 Harris et al., 1994a; Monegier et al., 1994; Royer et al., 1995) ; the major metabolite formed is a monohydroxylated derivative at C6 of the taxane ring not present in rat bile (Monsarrat et al., 1990) . Hydroxylated product on the phenyl at C3Ј is also observed in human bile, as well as the dihydroxylated molecule at C3Ј of the lateral chain and C6 of the taxane ring. Two distinct monooxygenases are involved in the hydroxylation of paclitaxel in the human liver; the formation of the C3Ј-derivative is clearly assigned to CYP3A4, whereas the 6-hydroxylated derivative is the major metabolite produced by a CYP2C protein identified as CYP2C8 (Cresteil et al., 1994; Harris et al., 1994b; Rahman et al., 1994) .
In contrast with paclitaxel, the biotransformation of docetaxel is similar in animals and humans (Vuilhorgne et al., 1995) . The chemical structure of purified metabolites was elucidated by mass spectrometry and NMR spectrometry and demonstrates that the metabolism of docetaxel involves an initial oxidation on the tert-butyl of the lateral side chain before its cyclization, both reactions catalyzed by CYP3A4 (Monegier et al., 1994; Marre et al., 1996; Royer et al., 1996; Shou et al., 1998) . These metabolites were also isolated from feces collected from patients given docetaxel (Sparreboom et al., 1996) . No hydroxylation on the taxane ring of docetaxel or on the phenyl group of the lateral chain has been reported in in vitro and in vivo studies. Thus, relatively minor modifications on the taxoid molecule have major consequences on the site of oxidation and the identity of the P450 1 isoform implicated in the reaction. Furthermore, the oxidative metabolism of paclitaxel and docetaxel strikingly reduced their biological activity. Thus, the 6-hydroxypaclitaxel is more than 30-fold less potent than paclitaxel in the in vitro inhibition of cell proliferation (Harris et al., 1994a; Kumar et al., 1995; Sparreboom et al., 1995) . Similarly, the hydroxylated metabolite of docetaxel shows poor in vitro cytotoxicity in P388 cells and in B16 tumor-bearing mice (Vuilhorgne et al., 1995) . Consequently, the biotransformation of taxoids at the hepatic level leads to the inactivation of the active parent molecule and consequently to a reduction of its therapeutic effect.
The purpose of the present study is to investigate the metabolism of paclitaxel and docetaxel analogs to define the structural elements orientating the hydroxylation on the taxoid molecule and determining the kinetic parameters for individual analogs. Since the only structural differences between paclitaxel and docetaxel are the replacement of the phenyl ring of the side chain at C13 by a t-butyl-oxy group and the absence of the acetyl in position 10, we choose to explore separately the role of these modifications on the biotransformation of taxoids by P450 (for structure see Fig. 1 ). Incubations were conducted with human liver microsomes to assess the overall biotransformation and with recombinant human P450 to ascribe individual reaction to a single P450 isoform.
Experimental Procedures
Materials. Paclitaxel was kindly provided by Bristol-Myers Squibb Co. (Wallington, CT) and docetaxel by Rhone Poulenc Rorer (Antony, France). 10-Deacetylpaclitaxel, 10-acetyldocetaxel, 10-deacetylbaccatin III, and baccatin III were isolated or synthesized as previously reported (Chauvière et al., 1981; Denis et al., 1988; Mangatal et al., 1989) . All chemicals were from the highest commercially available grade.
Microsome Preparation. Human hepatic tissues were collected and microsomes prepared from frozen samples, as stated previously (Cresteil et al., 1979) . The total cytochrome P450 content, the protein content, and the concentration of individual P450 isoforms were estimated as reported elsewhere (Cresteil et al., 1985 (Cresteil et al., , 1994 .
Expression of Recombinant P450. COS-1 cells or Ad293 cells were maintained at 37°C under 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 4500 mg/l D-glucose, 10% fetal calf serum, 100 U/ml penicillin, and 100 g/ml streptomycin. The preparation of stable transfectants expressing CYP1A1, 1A2, 3A4, and 3A7 in Ad293 cells was detailed previously (Lacroix et al., 1997; Sonnier and Cresteil, 1998) . A similar procedure was developed to generate stable transfectants of CYP2C8, 2C9, and 3A5. Full-length cDNA encoding CYP2C8, 2C9, and 3A5 were kindly provided by Dr. F. J. Gonzalez (NCI, Bethesda). Briefly, CYP3A5 cDNA was removed from pUC9 and 2C8 and 2C9 cDNAs from pUV-1 as EcoRI fragments and inserted in the correct orientation in the EcoRI site of pMT2 originated from the Genetics Institute (Cambridge, MA). Fifty micrograms of P450-pMT2 plasmid was transfected in COS-1 cells for transient expression by the calcium phosphate procedure, as reported by Lacroix et al. (1997) . Stable transfectants were obtained by transfection of Ad293 cells with 60 g of P450-pMT2 and 3 g of pIBW-3 plasmid containing the neomycin resistance gene. Seventytwo hours after transfection, selection was initiated with geneticin sulfate (1 mg/ml culture medium) for 2 to 3 weeks. Resistant clones derived from single colonies were harvested and grown individually in culture medium containing 50 g/ml geneticin for 2 to 3 additional weeks. Microsomes were prepared and their content in P450 protein was estimated by Western blot with antibodies purchased from Daiichi Chemicals (Tokyo, Japan) against the rat CYP2C6 and reacting with all human CYP2C proteins, from Daiichi Chemical for CYP3A4/5 or from Affiniti (Exeter, UK) for anti-CYP3A5. Clones selected showed the highest content in P450 protein and activity toward reference compounds; 6␤-hydroxylation of testosterone for CYP3A5 and dealkylation of methoxy trifluoromethylcoumarin for CYP2C. When tested with antibodies to CYP3A4/5 reacting with the two proteins, comparable intensities were obtained indicating that Ad293-3A4 and Ad293-3A5 expressed similar amount of CYP3A proteins. Immunochemically determined P450 level and activity expressed per milligram of microsomal protein were comparable in stable transfectants and liver microsomes.
Although Ad293 cells contain an appreciable NADPH-cyt P450 reductase activity, additional copies of the reductase gene could substantially stimulate the monooxygenase activity of CYP3A genes, as stated elsewhere (Ding et al., 1997) . The full-length cDNA encoding the human NADPH-cyt P450 reductase was excised from pUC19-HredL, provided by Dr. P. Urban (Gif, France) and inserted into the EcoRI site of pMT2 to give pMT2-Red. Fifty micrograms of pMT2-Red was transfected into stable transfectants expressing CYP3A4, 3A5, or 3A7 together with 3 g of pTK-Hyg, a selection marker bearing the hygromycin resistance gene (CLONTECH, Palo Alto, CA). After selection with 200 g/ml of the culture medium hygromycin B (Invitrogen, Carlsbad, CA) for 4 weeks, resistant clones were grown and screened for their reductase activity; clones showing the highest activity were selected for further experiments.
Metabolism of Taxoids.
Microsomal proteins corresponding to 0.3 nmol of P450 were incubated in a final volume of 1 ml of 50 mM sodium phosphate, pH 7.4, 5 mM MgCl 2 , 10% glycerol with a NADPH-generating system consisting in 0.1 mM NADP, 1 mM glucose 6-phosphate. Taxoids (10 mM dissolved in methanol) were added to a final concentration of 50 M except when otherwise indicated, and the reaction was initiated by the addition of glucose-6-phosphate dehydrogenase. After 30 min at 37°C, the reaction is stopped by the addition of 2.5 ml of ethyl acetate to extract the parent molecule and its metabolites. Extraction is repeated three times; organic phases were pooled and evaporated to dryness under a nitrogen stream. The residues, dissolved in 200 l of acetonitrile/water (70:30, v/v), were analyzed by HPLC and HPLC/MS. For K m determinations, taxoid concentrations ranged from 0 to 250 M; double reciprocal plots allowed the calculation of apparent K m and V m . For structural determinations, incubations were carried out for 1 h and were scaled up by 10 to obtain a sufficient amount of metabolites.
When incubated with stable transfectants, 50 M taxoids was added to 4 ml of culture medium without fetal calf serum in 75-cm 2 tissue culture flasks containing cells at near confluence. After 24 h at 37°C, cells were scraped with a rubber policeman and maintained in the culture medium to minimize loss of material, and 5 ml of ethyl acetate was added for extraction. The extraction step was repeated three times, and organic phases were pooled before evaporation.
Characterization and Quantification of Taxoids Metabolites. Metabolites and parent compounds were separated by reverse-phase HPLC, and peaks corresponding to the different products were quantified. The following HPLC conditions were used: 1) Ultrasphere ODS column, 4.6-mm ϫ 25-cm, C 18 (Beckman Coulter, Inc., Fullerton, CA,); 2) isocratic eluent MeOH/H 2 O 65:35 for paclitaxel and 10-deacetylpaclitaxel; linear gradient: 40 to 50% H 2 O/ MeOH, 0 to 50 min for baccatin III and 10-deacetylbaccatin III; linear gradient 30 to 60% H 2 O/CH 3 CN, 0 to 55 min for docetaxel and acetyldocetaxel; 3) UV detection at 235 nm and a flow rate of 0.8 ml/min. The HPLC system included a Waters (Milford, MA) model equipped with a 600 MS pump and an U6K injector and were linked to a Waters M991 photodiode array for UV detection at 235 nm. To characterize the structure of taxoid metabolites in microsome or cell extracts, we used on-line HPLC/MS with an atmospheric pressure chemical ionization-mass spectrometry interface mode, as previously reported (Royer et al., , 1996 . Chromatographic conditions were the same as those described above; microsome and cell extracts were dissolved in 100 l of a mixture of acetonitrile/water and introduced into the HPLC/MS system (TSQ 700; Thermo Finnigan MAT, San Diego, CA). Mass spectrometry data were acquired continuously in the full-scan mode (m/z 150-1200) at 2 ms/step.
Results
Metabolism of Paclitaxel. The biotransformation of paclitaxel by human liver microsomes has been extensively studied by us and others, and we checked in a first set of experiments the formation of known metabolites in our conditions ( Fig. 2 and 3 ). As expected, two oxidation products were resolved by HPLC from incubation mixtures of liver microsomes with 50 M paclitaxel and NADPH; the 6-hydroxy and the 3Ј-phenyl-hydroxy derivatives eluted at 9.5 and 16 min, respectively, in comparison with the parent molecule (20 min). These products were absent from incubations without NADPH. Their structures were explored by HPLC/MS and yielded fragments at m/z 286 (unchanged side chain at C13) and 569 (taxane ring) in the parent paclitaxel molecule shifting to either 302 or 585 after hydroxylation, which is in agreement with the structure already reported in the literature . The oxidation on the C2 benzoate ring could be excluded based on the shift of fragment from m/z 447 (Ϫlateral chain Ϫ C2 benzoate) to 463 observed only in material eluting at 9.5 min.
When paclitaxel is incubated for 24 h with cells expressing or not expressing recombinant human P450, different HPLC profiles can be observed; in control Ad293 cells (expressing no P450), only the formation of 7-epipaclitaxel could be demonstrated and accounted for about 10% of the paclitaxel added to the culture medium. This peak of 7-epipaclitaxel was present in incubations performed with all cell lines and probably resulted from a non-P450-dependent reaction occurring during the 24-h incubation period. The HPLC profile obtained with Ad293-2C9, Ad293-1A1, and Ad293-1A2 cells was similar and confirmed that these P450 proteins play no role in the oxidation of paclitaxel. In contrast, a prominent peak of metabolite can be detected with Ad293-2C8 cells with a retention time corresponding to 6-hydroxypaclitaxel. In the same conditions, Ad293-3A4 cells produced only the 3Ј-phenyl-hydroxy derivative, whereas Ad293-3A5 and Ad293-3A7 cells were not capable of forming this oxidation product. Collectively, these data suggest that the metabolic pathway of paclitaxel is rather clear; 6-hydroxypaclitaxel is produced exclusively by CYP2C8 and 3Ј-phenyl-hydroxypaclitaxel by CYP3A4.
Metabolism of 10-Deacetylpaclitaxel. The HPLC profile of incubation mixture of 10-deacetylpaclitaxel with liver microsomes in the 
FIG. 3. Chromatogram of incubation of paclitaxel with human liver microsomes.
Arrows refer to metabolites formed in the presence of NADPH eluting at 9.5 min (C3Ј-OH-paclitaxel) and 16 min (6-OH-paclitaxel).
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at ASPET Journals on June 22, 2017 dmd.aspetjournals.org presence of NADPH showed two peaks eluting at 11.5 and 12.5 min, respectively. In addition, the unchanged 10-deacetylpaclitaxel had a retention time of 16 min (Fig. 4) . These two peaks were absent from incubations run in absence of NADPH and were identified as oxidation products. HPLC/MS analysis of 10-deacetylpaclitaxel generated a parent ion at m/z 812 and fragments at m/z 527 (intact taxane ring), 405 (taxane ring-C2 benzoate), and 286 (unchanged side chain at C13). The peak eluting at 11.5 min yielded a parent ion at m/z 828 and fragments compatible with an hydroxylation on the benzoate ring at C2, with fragments at m/z 543, 405, and 286, whereas the peak eluting at 12.5 min displayed a parent ion at m/z 828 and fragments at m/z 543, 421, and 286, indicating that oxidation occurred on the taxane ring, probably in position 6.
Like paclitaxel, 10-deacetylpaclitaxel was steadily transformed by cells expressing P450 and by native Ad293 cells into its 7-epimer, having a retention time of 23 min; about 10 to 15% of the initial dose was recovered as the epimer after 24 h. In control Ad293 cells, no other product was identified. Similarly, Ad293-1A1 and Ad293-1A2 cells were not active toward 10-deacetylpaclitaxel. The peak eluted at 12.5 min was observed only when 10-deacetylpaclitaxel was incubated with Ad293-2C8 cells, whereas Ad293-2C9 cells were not capable to form this product. Conversely, the metabolite hydroxylated on the benzoate at C2 and eluted at 11.5 min was formed only by CYP3A proteins, although in variable amount; it is absent from incubates of Ad293-3A5 cells but present at a low content in Ad293-3A4 cells and at a higher concentration in Ad293-3A7 cell incubates.
Metabolism of Docetaxel. The metabolism of docetaxel by human liver microsomes was consistent with those reported earlier; a single peak of product eluting at 23.5 min was observed and identified by mass spectrometry as the hydroxylated derivative on the tert-butyl of the lateral chain, shifting its mass from m/z 282 to 298, whereas a fragment at m/z 182 (lateral chain Ϫ tert-butyl Ϫ O-CO) was recovered in the product as in the native docetaxel molecule, indicating that oxidation occurred on the tert-butyl moiety.
In control and P450-expressing cells, two peaks can be monitored at 38.5 and 45 min and represented the unchanged docetaxel and its 7-epimer, respectively. In native Ad293 cells, as well as in Ad293-1A1, Ad293-1A2, Ad293-2C8, Ad293-2C9, and Ad293-3A7 cells, no other products can by detected in HPLC profiles, whereas the pattern of docetaxel metabolites generated by Ad293-3A4 and Ad293-3A5 cells was more complex (Fig. 5) . The t-butyl hydroxylation was essentially mediated by Ad293-3A4 and to a lesser extent by Ad293-3A5 (0.110 and 0.034 nmol in 24 h, respectively). In addition to this oxidation product (marked with an asterisk) with a retention time of 24 min, two derivatives resulting from its cyclization (m/z 822; lateral chain 296) were also detected with retention times of 23 and 26 min. Epimers of the hydroxylated metabolite at t-butyl and its cyclized derivatives were also formed by Ad293-3A4 and Ad293-3A5 cells and were resolved with retention times of 32, 33, and 34 min, as previously identified (Shou et al., 1998) .
Metabolism of 10-Acetyldocetaxel. Metabolites generated during incubation of 10-acetyldocetaxel with liver microsomes in the presence of NADPH were resolved by HPLC and characterized by HPLC/MS (Fig. 6) . The unchanged 10-acetyldocetaxel eluted at 49 min with a parent ion m/z 850 and yielded fragments at m/z 794 (Ϫtert-butyl), 734 (Ϫtert-butyl Ϫ acetyl at C10), 569 (Ϫside chain at C13), 509 (Ϫside chain at C13 Ϫ acetyl at C10), and 282 (side chain at C13). It was accompanied by several peaks; the oxidation product eluted at 37 min was hydroxylated on the tert-butyl of the lateral chain (t-butyl-OH-10-acetyldocetaxel), with a parent ion at m/z 866 and
FIG. 4. Chromatogram of incubation of 10-deacetylpaclitaxel with human liver microsomes.
Arrows refer to metabolites formed in the presence of NADPH eluting at 11.5 min (C2-OH-10-deacetylpaclitaxel) and 12.5 min (C6-OH-10-deacetylpaclitaxel).
FIG. 5. Chromatogram of incubation of docetaxel with Ad293-3A4 cells.
Arrows refer to metabolites formed by Ad293-3A4 cells and absent from incubation with Ad293 cells. The asterisk indicates the C3Ј-OH-docetaxel produced by human liver microsomes. Like other taxoids, the epimerization of 10-acetyldocetaxel accounted for about 15% of the concentration of the parent drug in 24 h. No metabolite was produced during incubation with control Ad293, Ad293-1A1, Ad293-1A2, and Ad293-2C9 cells. In contrast, Ad293-2C8 cells were capable of forming a unique metabolite with a retention time of 44 min, which was identified as the hydroxylated derivative on the taxane ring. Conversely, only CYP3A4 was capable to actively carry out the hydroxylation of 10-acetyldocetaxel on the lateral chain at either the tert-butyl or the phenyl group but had no action on the taxane ring. These reactions were restricted to 3A4 since neither 3A5 nor 3A7 can support oxidation of 10-acetyldocetaxel.
Metabolism of Baccatin III. When the lateral chain at C13 is absent from taxoid molecules, the biotransformation rate is severely reduced and the low amount of metabolites of baccatin III and 10-deacetylbaccatin III formed during incubation with human liver microsomes or P450-expressing cell lines made illustrating their structure difficult. In our conditions, baccatin III was eluted at 36 min after two peaks containing baccatin derivatives with retention times of 26 and 31 min. Fragments of baccatin III (parent ion m/z 587) indicated ions at m/z 527 (Ϫacetyl), 405 (Ϫacetyl Ϫ benzoate at C2), and 345 (Ϫacetyl at C4 Ϫ benzoate at C2 Ϫ acetyl at C10). Fragments issued from the derivatives gave the same pattern with ions at m/z 543, 421, and 361 for a parent ion at m/z 603. This indicated that an oxygen atom was added to the taxane ring and was not compatible with an oxidation on the benzoate ring at C2, with expected fragments at m/z 603, 543, 405, and 345. These two hydroxylated metabolites on the taxane ring were produced only by Ad293-3A4 and Ad293-3A7 cells; all other P450-expressing cell lines were devoid of activity but retained the epimerization of baccatin. In addition to these two metabolites, a very low amount of hydroxylated metabolites of 7-epibaccatin can also be detected in HPLC but cannot be accurately analyzed in HPLC/MS.
Metabolism of 10-Deacetylbaccatin III. Extracts prepared from incubations of NADPH with 10-deacetylbaccatin and liver microsomes contained a single peak considered a direct metabolite, with a retention time of 23 versus 24 min for 10-deacetylbaccatin. The structure of this metabolite was verified by HPLC/MS; the protonated molecular ion (m/z 545) and characteristic fragment ions were 16 mass units greater than 10-deacetylbaccatin, indicating that an oxygen atom was added to the taxane ring.
Neither control Ad293 cells nor Ad293-1A1, Ad293-1A2, Ad293-2C8, and Ad293-2C9 cells generated an oxidation product of 10-deacetylbaccatin. Only Ad293-3A4 and Ad293-3A7 cells produced the derivative eluted, in a very limited amount, at 23 min.
Quantitative Metabolism of Taxoids by Human Liver Microsomes. The overall metabolism of taxoids and the balance between the different oxidative routes were investigated in liver microsomes and reflected the participation of individual P450 isoforms to the overall metabolism of taxoids by microsomes. The rate of biotransformation was quite variable, ranging from 0.36 to 4% of the substrate concentration transformed in 30 min by 1 mg of microsomal protein when taxoids were incubated at a concentration of 50 M. A general feature is related to the presence of an acetyl group in position 10 of the taxane ring, which strikingly activates the biotransformation rate by liver microsomes. The rate of reaction is 2-to 5-fold higher with baccatin III, 10-acetyldocetaxel, and paclitaxel than with 10-deacetylbaccatin III, docetaxel, and 10-deacetylpaclitaxel, respectively ( Table  1) .
Assuming that a single P450 protein is involved in individual reaction (Table 2) , we ascribed biotransformation and its kinetic parameter calculated from data obtained with human liver microsomes to isoform 2C8 or 3A4. The hydroxylation on the tert-butyl of docetaxel could be attributed to both CYP3A4 and 3A5, and the value determined in liver microsomes should be the sum of the two contributions. As already reported, the formation of 6-hydroxypaclitaxel was higher than the formation of the 3Ј-phenyl-hydroxylated derivative (63 versus 37% of total metabolites) and was associated with a higher V m , even if the K m value for the two reactions was similar. Using the ratio V m /K m to assess the efficiency of P450 in paclitaxel metabolism, CYP2C8 was found to be more effective than CYP3A4 (130 versus 35). The same ratio between 6-hydroxylation and C2-hydroxylation was observed with 10-deacetylpaclitaxel. The hydroxylation on the taxane ring largely exceeded the hydroxylation on the benzoate ring at C2 (72 versus 28% at 50 M 10-deacetylpaclitaxel), but the affinity of 10-deacetylpaclitaxel for both CYP3A4 and 2C8 was strikingly reduced. The K m value of 10-deacetylpaclitaxel and paclitaxel for CYP3A4 were 67 and 15 M, respectively, whereas the K m values for CYP2C8 were 200 and 15 M. Thus, the presence of the acetyl group in position 10 improved the affinity for P450 and would suggest that hydrophobic interactions existed between the substrate and the binding site of both P450 proteins.
With docetaxel a single primary metabolite resulting from the oxidation on the lateral chain was generated by CYP3A4 with an excellent affinity (2 M). Consequently, the ratio V m /K m was the highest in the series. 10-Acetyldocetaxel retained the same affinity for the 3A4-dependent reaction (4 to 7 M), but the hydroxylation on the taxane ring mediated by CYP2C8 exhibited a moderate affinity (50 Arrows refer to metabolites formed in the presence of NADPH eluting at 37 min (t-butyl-OH-10-acetyldocetaxel), 40 and 42 min (phenyl-OH-10-acetyldocetaxel), and 44 min (6-OH-10-acetyldocetaxel).
M). However, the V m of CYP2C8 largely exceeded the V m of CYP3A4. The higher affinity of 10-acetyldocetaxel for CYP3A4 than for CYP2C8 accounted for the preferential formation (74% of metabolites) of the 3Ј-phenyl-OH and t-butyl-OH derivatives when liver microsomes were incubated with 50 M 10-acetyldocetaxel.
The affinity of baccatin III and 10-deacetylbaccatin III for liver microsomes ranged from 25 to 200 M and the maximal velocities from 575 to 1920 pmol of metabolite formed in 1 min by 1 nmol of P450. These values were in the range of values calculated with other taxoids. The balance between the two unidentified metabolites of baccatin III was 4:1, the less abundant metabolite showing the lowest affinity and maximal velocity.
Collectively these data indicated that the affinity of taxoids for CYP3A4 was better than the affinity for CYP2C8, but this latter exhibited a higher maximal velocity than CYP3A4. Therefore, we can consider CYP3A4 as a high-affinity component involved in the biotransformation of taxoids compared with the low-affinity component CYP2C8.
Discussion
The rationale of this study was based on the observation that two changes in the structure of the taxoid molecule could shift the major hydroxylation site from the C6 of the taxane ring of paclitaxel to the side chain at C13 in docetaxel. Therefore, we intend to evaluate the impact of individual modification of the taxoid molecule on the site of hydroxylation and extent of the reaction by P450-dependent monooxygenases.
Data are summarized in Table 2 . CYP3A4 and to a minor extent CYP3A7 were the only P450 isoforms tested in this study capable to actively hydroxylate taxoid molecules lacking the side chain at C13, such as in baccatin III and 10-deacetylbaccatin III. The reaction occurred on the taxane ring probably in position 6, whereas CYP2C8 responsible for this reaction in paclitaxel had no activity. The presence of a tert-butyl group in the side chain at C3Ј, such as in docetaxel and 10-acetyldocetaxel, increased the overall oxidation of taxoids by CYP3A isoforms and orientated the metabolism toward the formation of the oxidation product on the tert-butyl group. A hydroxylation on a tert-butyl group by CYP3A4 has already been described for terfenadine, the tertiary butyl group being liable to oxidation because of its high number of available primary carbons (Yun et al., 1993) . The hydroxylated derivative was the unique primary metabolite formed from docetaxel and accounted for 74% of the total metabolite formation from 10-acetyldocetaxel by human liver microsomes, with a similar affinity for docetaxel and 10-acetyldocetaxel. CYP3A4 was the major contributor to this reaction, whereas CYP3A5 only moderately catalyzed this reaction, as already reported by Royer et al. (1996) and Shou et al. (1998) . Actually the affinity of CYP3A4 for docetaxel has been reported to be 10-fold higher than those of CYP3A5 and could explain why the participation of CYP3A5 to the biotransformation of taxoids at a dose of 50 M might be very low in relation with the low affinity of CYP3A5 for taxoids. Conversely, the presence of a benzamide group in the side chain favored the hydroxylation in position 6 of the taxane ring, with more than 60% of the metabolite formed from either paclitaxel or 10-deacetylpaclitaxel by CYP2C8.
Collectively these results suggested that the side chain plays a crucial role in determining the orientation of the taxoid molecule into the active site of P450 proteins. The presence of the side chain is required for a correct orientation of the substrate into the active site of CYP2C8 and to place the putative hydroxylation site (e.g., carbon 6 of the taxane ring) in the vicinity of the heme-oxygen complex. Its absence completely prevents any reaction by CYP2C8. The replacement of the tert-butyl group of the side chain by a phenyl ring facilitates the positioning of the substrate into the CYP2C8-active site and would probably suggest that hydrophobic interactions exist be- 
N.D., not determined.
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at ASPET Journals on June 22, 2017 dmd.aspetjournals.org tween the phenyl group of the side chain and hydrophobic residues of the CYP2C8 peptide chain via -bonding. Conversely, the presence of a benzamide group instead of a boc-amino group in the side chain reduces the hydroxylation by CYP3A4 through a decreased affinity for the protein. This effect may be related to different conformations of the side chain of paclitaxel and docetaxel, as proposed earlier . Another feature is the 2-to 5-fold increase of the overall hydroxylation rate of 10-deacetylbaccatin III, docetaxel, and 10-deacetylpaclitaxel by human liver microsomes when an acetyl group is added in position 10 of the taxane ring. This higher biotransformation results from either a stimulation of the catalytic velocity for baccatin and 10-acetyldocetaxel or an increased affinity for paclitaxel without modification of the catalytic efficiency. Both CYP3A4-and CYP2C8-dependent activities are stimulated, indicating that the presence of a hydrophobic group in position 10 stimulates the activity, but without striking modification of the balance between CYP3A4 and 2C8. However the addition of the acetyl group in position 10 of docetaxel allowed the 6-hydroxylation of 10-acetyldocetaxel by CYP2C8 but with a weaker affinity than the oxidation on the tert-butyl group by CYP3A4.
These observations attribute a major role in the substrate recognition by P450 to hydrophobic groups and to interaction between these hydrophobic groups and hydrophobic amino acid residues. Several key residues have been hypothesized to play an active role in the binding of substrates to CYP3A4 based on sequence alignment or after site-directed mutagenesis. Thus, aromatic residues Phe 215 , Phe 304 , and Tyr 307 (respectively Phe 181 , Phe 263 , and Tyr 266 when aligned on BM3 or cyp102 from Bacillus megaterium) could interact with groups of 3A4 substrates but are also present in CYP3A5 and 3A7 (Lewis et al., 1996) . Mutations in SRS4 within close proximity to the putative substrate-binding pocket have demonstrated altered oxidation products with progesterone but are similar in 3A4, 3A5, and 3A7 (Domanski et al., 1998) . Similarly, the highly conserved residue Ser 119 has been shown to play an important role in the active site topology of CYP3A4 but is also present in 3A5 and 3A7 (Roussel et al., 2000) . To date no definitive clue has been provided regarding the identity of amino acids involved in substrate recognition and orientation, and the sequence homology between 3A4, 3A5, and 3A7 could not explain the difference observed in the transformation of taxoids. In this respect, the use of substituted taxoids allows exploring the orientation of substrates into the active site of CYP3A and constitutes a useful tool to probe the hydrophobic pocket of these enzymes.
The biological activity of taxoids tested upon microtubule assembly or in in vitro cytotoxic assays has demonstrated a partial relationship between the hydrophobicity of taxoids and their interaction with tubulin. Thus paclitaxel, 10-deacetylpaclitaxel, docetaxel, and 10-acetyldocetaxel showed a very similar potency to inhibit microtubule disassembly and modification of substituents at C10 has no or little effect on the activity except when very large groups are branched at C10 (Guénard et al., 2000) . Furthermore, the addition of polar substituents has no effect in the tubulin assay. These data confirmed previous observations reporting that modifications at C10 (or C7) have generally no effect on the biological activity of taxoids (Parness et al., 1982) . In contrast the potent biological activity of taxoids is generally reduced by modification on the lateral chain of paclitaxel and docetaxel (Lataste et al., 1984) . Gueritte-Voegelein et al. (1991) and Guenard et al. (1993) reported that the configuration at position C2Ј and C3Ј of paclitaxel is important for the inhibition of microtubule assembly and postulated a positive correlation between the conformation of the side chain and the binding activity. These results differ from the striking difference reported here in the biotransformation of taxoids by P450 proteins and could be the basis for the design of molecule with high biological activity and low biotransformation.
